The anti-platelet drug cilostazol enhances heart rate and interrenal steroidogenesis and exerts a scant effect on innate immune responses in zebrafish
Rationale Cilostazol, an anti-platelet phosphodiesterase-3 inhibitor used for the treatment of
intermittent claudication, is known for its pleiotropic effects on platelets, endothelial cells and …
intermittent claudication, is known for its pleiotropic effects on platelets, endothelial cells and …
Beyond traditional pharmacology: evaluating phosphodiesterase inhibitors in autism spectrum disorder
Autism spectrum disorder (ASD) encompasses a range of neurodevelopmental conditions
characterized by differences in social communication and interaction, coupled with repetitive …
characterized by differences in social communication and interaction, coupled with repetitive …
The challenge of managing difficult to treat psychiatric conditions
A Serretti - International Clinical Psychopharmacology, 2023 - journals.lww.com
Autism spectrum disorder (ASD) is part of these cases; an integrative therapeutic approach
is usually suggested, and a range of treatments showed a variable degree of benefit (Howes …
is usually suggested, and a range of treatments showed a variable degree of benefit (Howes …
The anti-platelet drug cilostazol enhances interrenal steroidogenesis and exerts a scant effect on innate immune responses in zebrafish
WC Chang, MJ Chen, YF Chen, CW Chou, YJ Chuang… - bioRxiv, 2022 - biorxiv.org
Rationale Cilostazol, an anti-platelet phosphodiesterase-3 inhibitor used for the treatment of
intermittent claudication, is known for its pleiotropic effects on platelets, endothelial cells and …
intermittent claudication, is known for its pleiotropic effects on platelets, endothelial cells and …